what is a glp-1 antagonist Chemical structures of receptor antagonists. Representative A summary of the actions
Description
12nd ed
2021 [cited 2026 Jan 9]
The exact mechanism is not fully understood and varies between individuals
[2] Dulaglutide (Trulicity), another once-weekly injectable GLP-1 agonist, demonstrates a somewhat more favourable gastrointestinal tolerability profile in some studies, with nausea reported in approximately 8-12% of patients at lower doses, though rates increase with higher doses (3
Weight loss compounds present a fundamental problem: they typically require much larger doses to be effective than can realistically be delivered through the skin
